INMB: UK Approves PIP
The UK Medicines & Healthcare Products Regulatory Agency approves the Pediatric Investigation Plan for INmune Bio's Ebstrocel for Recessive Dystrophic Epidermolysis Bullosa
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.